This is a Pre-Solicitation notice for the Department of Veterans Affairs, Network Contracting Office 23, for the procurement of Blood Bank Automation System Supply at the Minneapolis VAMC, Minneapolis, MN 55417. The NAICS code for this procurement is 325413 In-Vitro Diagnostic Substance Manufacturing with a size standard of 1,250 employees. Potential offerors are responsible for monitoring this site for the release of the solicitation package and any other pertinent information and for downloading their own copy of the solicitation package. Any amendments issued to this solicitation will ONLY be available on this site. Offerors are advised that they are responsible for obtaining all amendments. All questions must be submitted in writing to the Contracting Specialist at joseph.bloomer@va.gov. No telephone inquiries will be accepted. This notice does not obligate the Government to award a contract neither does it obligate the Government to pay for any quotes or proposal preparation costs. The Government is not obligated to issue a solicitation as a result of this notice. No other information is available until issuance of the solicitation. All interested parties must be registered in System for Award Management (SAM) to be eligible for award. Registration information can be found at www.sam.gov. Statement of Work Blood Bank Automation System 1. Basic Requirement: The Minneapolis VA Health Care System Blood Bank Laboratory located at 1 Veterans Drive, Minneapolis, MN 55417, hereinafter referred to as MVAHCS, is in need of a contract to provide a cost-per-test or reagent rental for one primary automated blood bank analyzer and two backup manual blood bank analyzers. Both primary automated and backup manual analyzers must be column-agglutination based technology for red cell antibody detection. All costs shall be figured into the price of the reagents, supplies, and consumables. This agreement is to include one primary automated analyzer, two backup manual analyzers (including both an incubator and centrifuge), one uninterruptible power supply (UPS), installation, validation, training, customer service, technical support, preventative maintenance, equipment service (including parts, labor, and travel), and all shipping costs. The analyzers may be placed in a temporary location for validation and need to be moved to a permanent location after they re validated for use. Contractor will be responsible for moving analyzers for this one time move, at no cost to the Government. 2. Contract Type and Terms: The MVAHCS will award a 5-year IDIQ with 6 ordering periods, firm, fixed-price, indefinite delivery indefinite quantity contract for all items listed in the Schedule of Items. Contract use will be limited to the MVAHCS. The effective ordering period of the contract shall be from 4/1/25-3/31/30. The ordering period of the contract shall be: Year 1 Pricing Period: 4/1/25-9/30/25 Year 2 Pricing Period: 10/1/25-9/30/26 Year 3 Pricing Period: 10/1/26-9/30/27 Year 4 Pricing Period: 10/1/27-9/30/28 Year 5 Pricing Period: 10/1/28-9/30/29 Year 6 Pricing Period: 10/1/29-3/31/30 3. Estimated Quantities: The tests listed in the Test Menu are estimated annual requirements. The MVAHCS attempts to be as accurate as possible when providing estimated quantities, however, actual quantities required may vary from quantities listed. All reagents, supplies, and consumables to support testing will be requested on an on demand, as needed basis. Test Menu ABO Rh and (3 cell) Antibody Screen = 11,000 ABO Rh = 1500 Antibody ID = 230 Donor unit retypes ABO Rh = 300 Donor unit retypes ABD = 1000 Anti-C = 200 Anti-c = 100 Anti-E = 200 Anti-e = 25 Immediate Spin (IS) Crossmatch = 900 Anti-Human Globulin (AHG) Crossmatch = 600 Direct Antiglobulin Test (DAT) = 350 4. Technical Requirements: The LIS interface system must be established with VBECS prior to contract award. Both primary automated and backup manual analyzers must be approved by the Food and Drug Administration (FDA). Both primary automated and backup manual analyzers must be column-agglutination based technology for red cell antibody detection. Primary analyzer must have capabilities to load reagents and supplies to process multiple specimens without reloading consumables. Primary analyzer must use regular saline without the addition of an external buffer. Primary analyzer average turn-around-time for a Type and Screen must not exceed 35 minutes. Primary analyzer must sit on the counter and not exceed dimensions of 31 D x 48 W x 42 H. Primary analyzer must have sample capacity for at least 10 samples. Primary analyzer must have continuous access with STAT capability. Primary analyzer must have automatic cap detection. Primary analyzer must have automatic clot detection. Primary analyzer must have automatic liquid level detection. Primary analyzer must be capable of performing the following tests: ABO/Rh Antibody Screen Antibody Identifi